SNHG6 and colorectal cancer: However, in Meng’ study, they verified that SNHG6 was downregulated in colorectal cancer tissues, suppress ETS1 via the PI3K/AKT/mTOR pathway to inhibit CRC cell proliferation and metastasis [28].